OVERWEIGHT AND/OR OBESITY
Clinical trials for OVERWEIGHT AND/OR OBESITY explained in plain language.
Never miss a new study
Get alerted when new OVERWEIGHT AND/OR OBESITY trials appear
Sign up with your email to follow new studies for OVERWEIGHT AND/OR OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New monthly shot could help people with obesity shed pounds
Disease control Not yet recruitingThis study tests a once-monthly injection called berobenatide to help adults with overweight or obesity lose weight. About 954 participants will receive either the drug or a placebo for 20 months. The goal is to see if the drug is safe and effective for weight loss, including in …
Matched conditions: OVERWEIGHT AND/OR OBESITY
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 04:09 UTC
-
Can text messages and coaching boost diet success in weight loss apps?
Disease control Not yet recruitingThis study looks at whether adding tools like a goal planner, personalized texts, or health coach sessions helps adults follow their diet goals better in a 6-month mobile weight loss program. About 580 overweight or obese adults will take part. The goal is to find the best combin…
Matched conditions: OVERWEIGHT AND/OR OBESITY
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:53 UTC
-
Pfizer launches new drug combo to tackle obesity epidemic
Disease control Not yet recruitingThis study tests two experimental drugs, PF-08653945 and PF-08653944, given alone or together, to help adults with overweight or obesity lose weight. About 872 participants will receive either the drugs or a placebo. The main goal is to see how much weight they lose and if the dr…
Matched conditions: OVERWEIGHT AND/OR OBESITY
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 18, 2026 11:58 UTC